Welcome to our dedicated page for ModivCare news (Ticker: $MODV), a resource for investors and traders seeking the latest updates and insights on ModivCare stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ModivCare's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ModivCare's position in the market.
Modivcare Inc. (MODV) reported Q1 2024 financial results with service revenue of $684.5 million, a 3.3% increase from Q1 2023. The company had a net loss of $22.3 million and adjusted EBITDA of $32.1 million. They won $171.2 million in NEMT total contract value in Q1 2024. The CEO is optimistic about achieving a run-rate adjusted EBITDA of $220-230 million by Q4 2024.